Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.44M Sell
3,988
-1,518
-28% -$520K 0.02% 147
2026
Q1
$1.95M Buy
5,506
+528
+11% +$188K 0.02% 138
2025
Q4
$1.63M Buy
4,978
+1,788
+56% +$567K 0.02% 144
2025
Q3
$897K Buy
+3,190
New +$925K 0.01% 175
2024
Q4
– Sell
-8,834
Closed -$2.82M – 160
2024
Q3
$2.82M Buy
8,834
+6,636
+302% +$2.17M 0.04% 102
2024
Q2
$694K Sell
2,198
-130
-6% -$38.2K 0.01% 124
2024
Q1
$663K Hold
2,328
– – 0.01% 125
2023
Q4
$674K Sell
2,328
-36
-2% -$9.81K 0.01% 127
2023
Q3
$635K Sell
2,364
-184
-7% -$45.9K 0.01% 120
2023
Q2
$569K Sell
2,548
-426
-14% -$98.8K 0.01% 123
2023
Q1
$719K Buy
+2,974
New +$730K 0.02% 110

Other funds holding AMGN

ABN AMRO Bank's AMGN Position: Q2 2026 in Review

ABN AMRO Bank reduced its Amgen (AMGN) stake by 28% in Q2 2026, selling an estimated $520K and leaving 3,988 shares worth $1.44M. The position accounts for 0.02% of the portfolio, ranked #147.

ABN AMRO Bank first reported a position in AMGN in Q1 2023 and has held it in 11 quarters since. The position peaked at $2.82M in Q3 2024. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • ABN AMRO Bank held 3,988 shares of Amgen worth $1.44M as of Q2 2026.
  • ABN AMRO Bank sold 1,518 Amgen shares in Q2 2026, an estimated $520K.
  • Amgen made up 0.02% of ABN AMRO Bank's portfolio in Q2 2026, its #147 holding.
  • ABN AMRO Bank first reported a position in Amgen in Q1 2023 and has held it in 11 quarters since.
  • ABN AMRO Bank's Amgen position peaked at $2.82M in Q3 2024.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on ABN AMRO Bank's 13F filing for Q2 2026, filed 6 Aug 2026.